Treace Medical Concepts, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Treace Medical Concepts, Inc. stock issued during period, value, new issues for the quarter ending 2023-03-31 was $107.53M.
- Treace Medical Concepts, Inc. stock issued during period, value, new issues for the quarter ending 2021-12-31 was $0.00.
- Treace Medical Concepts, Inc. stock issued during period, value, new issues for the quarter ending 2021-09-30 was $0.00.
- Treace Medical Concepts, Inc. stock issued during period, value, new issues for the quarter ending 2021-06-30 was $107.61M.
- Treace Medical Concepts, Inc. stock issued during period, value, new issues for fiscal 2023 was $107.53M.
- Treace Medical Concepts, Inc. stock issued during period, value, new issues for fiscal 2021 was $107.61M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2023-12-31 | $107.53M 10-K · filed 2026-02-27 | |
| 2023-03-31 | $107.53M 10-Q · filed 2024-11-05 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $107.61M 10-K · filed 2024-02-27 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | |
| 2021-06-30 | $107.61M 10-Q · filed 2022-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |